Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: PALOMA, an open-label, multicenter, dose escalation phase 1b study.

被引：2
|
作者：
Krebs, Matthew
Johnson, Melissa Lynne
Cho, Byoung Chul
Park, Keunchil
Haddish-Berhane, Nahor
Zemlickis, Donna
Mitselos, Anna
Meacle, Francis
Knoblauch, Roland Elmar
Hellemans, Peter
Minchom, Anna Rachel
机构：
[1] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Manchester, Lancs, England
[2] Manchester Acad Hlth Sci Ctr, Christie NHS Fdn Trust, Manchester, Lancs, England
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] Yonsei Univ, Yonsei Canc Ctr, Coll Med, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[6] Janssen R&D, Spring House, PA USA
[7] Janssen R&D, Toronto, ON, Canada
[8] Janssen R&D, Beerse, Belgium
[9] Royal Marsden Inst Canc Res, Drug Dev Unit, Sutton, Surrey, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.TPS3150
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3150
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Mavorixafor for Patients with Chronic Neutropenic Disorders: Results from a Phase 1b, Open-Label, Multicenter Study
    Warren, Julia T.
    Walkovich, Kelly J.
    Bolyard, Audrey Anna
    Dickerson, Kathryn E.
    Walter, Jolan E.
    Cadavid, Diego
    Chapa, Eloisa
    Chen, Kelly
    MacLeod, Richard
    Peters, Katie
    Polisson, Richard
    Dale, David C.
    BLOOD, 2022, 140 : 1408 - 1410
  • [42] A phase I, open-label, multicenter, dose escalation safety and tolerability study of oncolytic virus OVV-01 in advanced solid tumors
    Hua, Y.
    Wang, C.
    Li, F.
    Han, Y.
    Zuo, D.
    Lv, Y.
    Peng, Y.
    Chen, J.
    Yuan, R.
    Zhang, F.
    Wang, Y.
    Wu, H.
    Zhou, G.
    Wang, S.
    Li, N.
    Lu, Y.
    Lin, Q.
    ANNALS OF ONCOLOGY, 2024, 35 : S677 - S677
  • [43] A PHASE 1, FIRST IN HUMAN, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY OF TST005 IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
    Chen, Lei
    Tolcher, Anthony
    Gabrail, Nashat
    Barve, Minal
    Wu, Xiaohua
    Zhang, Jian
    Shi, Michael
    Qi, Chuan
    Yu, Steven
    Yao, Jenny
    Wang, Jianming
    Cavanaugh, Christopher
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A802 - A802
  • [44] A multicenter, open-label, phase 1a study of HC-5404 in patients with advanced solid tumors
    Dudek, Arkadiusz Z.
    O'Shaughnessy, Joyce
    Piha-Paul, Sarina A.
    Uprety, Dipesh
    Kitchens, Benjamin Lee
    Hutson, Thomas E.
    Rank, Brian H.
    Stokes, Michael
    Dudgeon, Crissy
    Surguladze, David
    Lightcap, Eric
    Drees, Jeremy
    Harrison, Ben
    Li, Richard
    LaCayo, Ashley
    Mattson, Paulette
    Bose, Nandita
    Karim, Dhamina
    Gargano, Michele Anne
    Iglesias, Jose Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] A Phase 1, Open-Label, Multicenter, Dose Escalation Safety Trial of Lyophilized Platelets in Bleeding Thrombocytopenic Patients
    Perez, Jose A. Cancelas
    Ohanian, Maro
    Davenport, Robertson
    Pullarkat, Vinod
    Hervig, Tor Audun
    Broome, Catherine
    Szczepiorkowski, Zbigniew M.
    Pidcoke, Heather
    Pehta, Joan C.
    Fitzpatrick, G. Michael
    TRANSFUSION, 2019, 59 : 8A - 8A
  • [46] A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer
    Sanjay Goel
    Umang Swami
    Kirushna Kumar
    Christian Dittrich
    Larisa Reyderman
    Minish Jain
    Joseph Aisner
    James Song
    Daniel P. Petrylak
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 567 - 578
  • [47] UPDATED RESULTS FROM A MULTICENTER, OPEN-LABEL, DOSE-ESCALATION PHASE 1B/2 STUDY OF SINGLE-AGENT OPROZOMIB (OPZ) IN PATIENTS (PTS) WITH HEMATOLOGIC MALIGNANCIES, INCLUDING MULTIPLE MYELOMA (MM)
    Vij, R.
    Savona, M.
    Siegel, D.
    Kaufman, J. L.
    Badros, A.
    Ghobrial, I.
    Paner, A.
    Jagannath, S.
    Jakubowiak, A.
    Mikhael, J.
    Kapoor, P.
    Neuman, L.
    Obreja, M.
    Berdeja, J.
    HAEMATOLOGICA, 2015, 100 : 251 - 251
  • [48] A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer
    Goel, Sanjay
    Swami, Umang
    Kumar, Kirushna
    Dittrich, Christian
    Reyderman, Larisa
    Jain, Minish
    Aisner, Joseph
    Song, James
    Petrylak, Daniel P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (03) : 567 - 578
  • [49] A phase I, open label, multicenter dose escalation study of AZD2811 nanoparticle in patients with advanced solid tumors.
    Johnson, Melissa Lynne
    Cosaert, Jan G. C. E.
    Falchook, Gerald Steven
    Jones, Suzanne Fields
    Strickland, Donald
    Greenlees, Carol
    Charlton, Julie
    MacDonald, Alexander
    Overend, Philip
    Adelman, Carrie
    Burris, Howard A.
    Pease, Elizabeth J.
    Patel, Gargi Surendra
    Wang, Judy Sing-Zan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] A Phase 1, Open-label, Dose-escalation Study of Oral Administration of the Investigational Agent MLN0128 in Combination with Paclitaxel (P) in Patients (pts) with Advanced Solid Malignancies
    Burris, H.
    Hart, L.
    Kurkjian, C.
    Berk, G.
    Lipman, P.
    Patel, C.
    Rommel, C.
    Martin, M.
    Infante, J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 186 - 186
12345